BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31153837)

  • 41. Benign cystic neoplasm and endocrine tumours of the pancreas--when and how to operate--an overview.
    Beger HG; Poch B; Vasilescu C
    Int J Surg; 2014; 12(6):606-14. PubMed ID: 24742543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term Metabolic Morbidity and Steatohepatosis Following Standard Pancreatic Resections and Parenchyma-sparing, Local Extirpations for Benign Tumor: A Systematic Review and Meta-analysis.
    Beger HG; Mayer B; Vasilescu C; Poch B
    Ann Surg; 2022 Jan; 275(1):54-66. PubMed ID: 33630451
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thirty-day outcomes underestimate endocrine and exocrine insufficiency after pancreatic resection.
    Lim PW; Dinh KH; Sullivan M; Wassef WY; Zivny J; Whalen GF; LaFemina J
    HPB (Oxford); 2016 Apr; 18(4):360-6. PubMed ID: 27037206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm.
    Tang RS; Weinberg B; Dawson DW; Reber H; Hines OJ; Tomlinson JS; Chaudhari V; Raman S; Farrell JJ
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):815-9; quiz 719. PubMed ID: 18602036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
    Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
    Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short- and long-term outcomes after enucleation of pancreatic tumors: An evidence-based assessment.
    Zhou Y; Zhao M; Wu L; Ye F; Si X
    Pancreatology; 2016; 16(6):1092-1098. PubMed ID: 27423534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas.
    Daudé M; Muscari F; Buscail C; Carrère N; Otal P; Selves J; Buscail L; Bournet B
    World J Gastroenterol; 2015 Mar; 21(9):2658-67. PubMed ID: 25759534
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
    Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Central pancreatectomy: single-center experience of 50 cases.
    Adham M; Giunippero A; Hervieu V; Courbière M; Partensky C
    Arch Surg; 2008 Feb; 143(2):175-80; discussion 180-1. PubMed ID: 18283143
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surgical treatment and prognosis of 96 cases of intraductal papillary mucinous neoplasms of the pancreas: a retrospective cohort study.
    Tian X; Gao H; Ma Y; Zhuang Y; Yang Y
    Int J Surg; 2015 Jan; 13():49-53. PubMed ID: 25461854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Virtual CO2 MDCT pancreatography: a new feasible technique for minimally invasive pancreatectomy in intraductal papillary mucinous neoplasms.
    Sugimoto M; Yasuda H; Koda K; Suzuki M; Yamazaki M; Tezuka T; Kosugi C; Higuchi R; Takenoue T; Yamamoto S; Watayo Y; Yagawa Y; Tsuchiya T
    Hepatogastroenterology; 2008; 55(81):270-4. PubMed ID: 18507123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Meta-analysis of surgical outcome after enucleation versus standard resection for pancreatic neoplasms.
    Hüttner FJ; Koessler-Ebs J; Hackert T; Ulrich A; Büchler MW; Diener MK
    Br J Surg; 2015 Aug; 102(9):1026-36. PubMed ID: 26041666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intraductal Papillary Mucinous Neoplasms of The Pancreas: A Nationwide Registry-Based Study.
    Aronsson L; Andersson B; Andersson R; Tingstedt B; Bratlie SO; Ansari D
    Scand J Surg; 2018 Dec; 107(4):302-307. PubMed ID: 29637834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Laparoscopic duodenum and spleen-preserving total pancreatectomy: A novel surgical technique for pancreatic intraductal papillary mucinous neoplasms.
    Wu J; Hu Q; Jin L; Yao W; Zhang C; Hu Z; Zhang Y
    Biosci Trends; 2019 Nov; 13(5):456-460. PubMed ID: 31611521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term surveillance is necessary after operative resection for intraductal papillary mucinous neoplasm of the pancreas.
    Hirono S; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
    Surgery; 2016 Aug; 160(2):306-17. PubMed ID: 27236360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience.
    Marsoner K; Haybaeck J; Csengeri D; Waha JE; Schagerl J; Langeder R; Mischinger HJ; Kornprat P
    BMC Cancer; 2016 Nov; 16(1):844. PubMed ID: 27809876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas.
    Srinivasan N; Koh YX; Goh BKP
    Surgery; 2019 May; 165(5):929-937. PubMed ID: 30577952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A resected case of two branch duct-type intraductal papillary mucinous neoplasms showing different clinical courses after a two-year follow-up.
    Shibata H; Ohike N; Norose T; Isobe T; Suzuki R; Imai H; Shiokawa A; Takimoto M; Tabuchi A; Takano Y; Yamamura E; Nagahama M; Takeyama N; Yokomizo K; Mizukami H; Tanaka JI; Aoki T; Murakami M
    Clin J Gastroenterol; 2017 Jun; 10(3):274-278. PubMed ID: 28258561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.
    Schnelldorfer T; Sarr MG; Nagorney DM; Zhang L; Smyrk TC; Qin R; Chari ST; Farnell MB
    Arch Surg; 2008 Jul; 143(7):639-46; discussion 646. PubMed ID: 18645105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intraductal papillary mucinous neoplasms of the pancreas - a cost-effectiveness analysis of management strategies for the branch-duct subtype.
    Aronsson L; Ansari D; Andersson B; Persson U; Fridhammar A; Andersson R
    HPB (Oxford); 2018 Dec; 20(12):1206-1214. PubMed ID: 30064727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.